Mechanisms of PhIP-induced dopaminergic neurotoxicity
PhIP 诱导多巴胺能神经毒性的机制
基本信息
- 批准号:9104730
- 负责人:
- 金额:$ 33.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridineAcuteAddressAffectAmericanAnimal ModelAnimalsBehaviorBehavioralBiochemicalBiological MarkersBrainBreastCYP1A1 geneCarcinogensCellsChronicDNADNA AdductsDNA Sequence AlterationDataDevelopmentDietDiseaseDisease modelDomestic FowlsDoseEnvironmental Risk FactorEnzymesEpidemiologyEssential TremorEtiologyEventExhibitsFishesGene MutationGeneticGoalsHigh temperature of physical objectHumanHydroxylationIn VitroIncidenceLRRK2 geneLaboratoriesLaboratory AnimalsLeadLinkLipidsMalignant NeoplasmsMeasurementMeasuresMeatMediatingMetabolismMethodsModelingModificationMotorMovement DisordersMusMutateMutationN hydroxylationNerve DegenerationNeurodegenerative DisordersNeurogliaNeuronsNeurotoxinsNeurotransmittersOxidative StressPaperParkinson DiseasePathologyPathway interactionsPenetrancePesticidesPopulationPositioning AttributePreventionProcessProstateProteinsPublishingRattusRecommendationResearchRoleRotenoneSolventsStagingSulfhydryl CompoundsSystemTechniquesTertiary Protein StructureTestingTherapeuticTimeTissuesToxic Environmental SubstancesTransgenic OrganismsUrsidae Familyadductbasecookingdisease-causing mutationdisorder riskdopaminergic neuronexperienceexposed human populationexposure routefollow-upgene environment interactiongenotoxicityheterocyclic aromatic aminesin vivoin vivo Modelnervous system disorderneurobehavioralneurochemistryneurotoxicneurotoxicitynoveloxidationoxidative damagepre-clinicalpublic health relevancepyridineresearch studysuccesssynucleintherapeutic targettoxicanttoxicant interactionuptake
项目摘要
DESCRIPTION (provided by applicant): The causes of most Parkinson's disease (PD) cases are unknown, ~90% are 'sporadic', ~10% are attributed to inheritance. Environmental factors, including pesticides and solvents, have long been suspected, but no toxicant has been convincingly identified. Most cases are thought to arise from gene -environment interactions. A specific example is leucine-rich repeated kinase 2 (LRRK2), a large multi-domain protein with an unknown endogenous function. Numerous LRRK2 mutations cause PD. However, incomplete penetrance in humans and heightened sensitivity to dopaminergic (DA) neuron toxicants in animals expressing mutations suggest the importance of gene-environment interactions. Mounting data from the Cannon laboratory and others suggests that heterocyclic aromatic amines (HAAs) are neurotoxic and associated with neurodegenerative diseases, including PD. HAAs have been primarily investigated as carcinogens in laboratory animals and as potential human carcinogens. HAAs are formed during high temperature meat and poultry cooking. Thus, chronic HAA exposure through diet may be much more common and occur at higher levels than for many environmental toxicants. This proposal tests the hypothesis that: 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most mass abundant HAA in cooked meats and poultry, exhibits selective dopaminergic neurotoxicity by a newly proposed mechanism of neurotoxic action through N-hydroxylation, a metabolite in common with PhIP's mediated genotoxicity. Our data suggests that mechanistic studies on PhIP neurotoxicity are critical to understanding a potential role in PD. The major goals of this proposal are to: 1) Characterize PhIP-mediated neurotoxicity in vivo; 2) Determine if PhIP exposure potentiates pathology in animals expressing mutated (G2019S) LRRK2 (the most common genetic cause of PD); 3) Identify key mechanism(s) of PhIP-mediated DA-selective neurotoxicity through examination of whether N-hydroxylation is a key pathogenic event, and by assessing the propensity of N-oxidized PhIP metabolites to broadly form adducts with major biomolecules. Modifications and adduct formation in specific PD-implicated proteins will also be examined. Success of this project will lead to several major advances. 1) Identification of a possible causative factor: PhIP is a common toxicant produced in cooked meats and may be consumed in higher doses than rarely encountered known DA toxicants; 2) Creation of a new gene-environment interaction model utilizing the most common PD causing-mutation and a compound to which humans are widely exposed; 3) New PD mechanisms: mechanistic studies would likely identify novel pathogenic pathways that may be therapeutic targets; 4) Prompt follow-up epidemiological and biomarker studies. In summary, using both in vivo and in vitro systems, we will carefully characterize PhIP-induced neurodegeneration and identify mechanisms of DA neurotoxicity. If PhIP exposure is proven to have a causative role in PD, then recommendations can be provided to the public because PhIP exposure can be mitigated by changes in cooking methods.
描述(由申请人提供):大多数帕金森病(PD)病例的原因尚不清楚,约90%为“散发性”,约10%归因于遗传。环境因素,包括农药和溶剂,长期以来一直被怀疑,但没有令人信服的有毒物质已被确定。大多数病例被认为是由基因-环境相互作用引起的。一个具体的例子是富含亮氨酸的重复激酶2(LRRK 2),一种具有未知内源性功能的大型多结构域蛋白。许多LRRK 2突变导致PD。然而,人类的不完全突变和表达突变的动物对多巴胺能(DA)神经元毒物的敏感性增加表明基因-环境相互作用的重要性。来自Cannon实验室和其他实验室的大量数据表明,杂环芳香胺(哈斯)具有神经毒性,并与神经退行性疾病(包括PD)相关。哈斯主要作为实验室动物的致癌物和潜在的人类致癌物进行研究。哈斯是在高温肉类和家禽烹饪过程中形成的。因此,与许多环境毒物相比,通过饮食长期接触HAA可能更为常见,而且接触水平更高。本提案检验了以下假设:2-氨基-1-甲基-6-苯基咪唑[4,5-B]吡啶(PhIP)是熟肉和家禽中含量最高的HAA,通过新提出的N-羟基化神经毒性作用机制(与PhIP介导的遗传毒性相同的代谢物)显示出选择性多巴胺能神经毒性。我们的数据表明,PhIP神经毒性的机制研究对于理解PD的潜在作用至关重要。本提案的主要目标是:1)表征PhIP介导的体内神经毒性; 2)确定PhIP暴露是否会增强表达突变(G2019 S)LRRK 2的动物的病理学(PD最常见的遗传原因); 3)通过检查N-羟基化是否是关键致病事件来鉴定PhIP介导的DA选择性神经毒性的关键机制,以及通过评估N-氧化PhIP代谢物与主要生物分子广泛形成加合物的倾向。还将检查特定PD相关蛋白质的修饰和加合物形成。该项目的成功将带来几项重大进展。1)鉴定可能的致病因素:PhIP是熟肉中产生的常见毒物,可能比罕见的已知DA毒物消耗更高的剂量; 2)利用最常见的PD致病突变和人类广泛暴露的化合物创建新的基因-环境相互作用模型; 3)新的PD机制:机制研究可能会发现新的致病途径,可能是治疗靶点; 4)及时随访流行病学和生物标志物研究。总之,使用体内和体外系统,我们将仔细表征PhIP诱导的神经变性和确定DA神经毒性的机制。如果事实证明PhIP暴露对PD具有致病作用,则可以向公众提供建议,因为PhIP暴露可以通过改变烹饪方法来减轻。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason R Cannon其他文献
Jason R Cannon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason R Cannon', 18)}}的其他基金
Mechanisms of PhIP-induced dopaminergic neurotoxicity
PhIP 诱导多巴胺能神经毒性的机制
- 批准号:
10595271 - 财政年份:2023
- 资助金额:
$ 33.35万 - 项目类别:
PFOS-induced dopaminergic neurodegeneration across nematode, amphibian, and rodent models
线虫、两栖动物和啮齿动物模型中全氟辛烷磺酸诱导的多巴胺能神经变性
- 批准号:
10042289 - 财政年份:2020
- 资助金额:
$ 33.35万 - 项目类别:
PFOS-induced dopaminergic neurodegeneration across nematode, amphibian, and rodent models
线虫、两栖动物和啮齿动物模型中全氟辛烷磺酸诱导的多巴胺能神经变性
- 批准号:
10241311 - 财政年份:2020
- 资助金额:
$ 33.35万 - 项目类别:
PFOS-induced dopaminergic neurodegeneration across nematode, amphibian, and rodent models
线虫、两栖动物和啮齿动物模型中全氟辛烷磺酸诱导的多巴胺能神经变性
- 批准号:
10289079 - 财政年份:2020
- 资助金额:
$ 33.35万 - 项目类别:
PhIP-induced neurodegeneration: mechanisms and relevance to Parkinson's disease
PhIP 诱导的神经变性:机制及其与帕金森病的相关性
- 批准号:
8643407 - 财政年份:2014
- 资助金额:
$ 33.35万 - 项目类别:
PhIP-induced neurodegeneration: mechanisms and relevance to Parkinson's disease
PhIP 诱导的神经变性:机制及其与帕金森病的相关性
- 批准号:
8792389 - 财政年份:2014
- 资助金额:
$ 33.35万 - 项目类别:
New Approaches to Gene-environment Interaction Modeling in Parkinson's Disease
帕金森病基因-环境相互作用建模的新方法
- 批准号:
8350767 - 财政年份:2012
- 资助金额:
$ 33.35万 - 项目类别:
New Approaches to Gene-environment Interaction Modeling in Parkinson's Disease
帕金森病基因-环境相互作用建模的新方法
- 批准号:
8610308 - 财政年份:2012
- 资助金额:
$ 33.35万 - 项目类别:
New Approaches to Gene-environment Interaction Modeling in Parkinson's Disease
帕金森病基因-环境相互作用建模的新方法
- 批准号:
8424270 - 财政年份:2012
- 资助金额:
$ 33.35万 - 项目类别:
New Approaches to Gene-environment Interaction Modeling in Parkinson's Disease
帕金森病基因-环境相互作用建模的新方法
- 批准号:
8089751 - 财政年份:2011
- 资助金额:
$ 33.35万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 33.35万 - 项目类别:
Operating Grants